Which safety measures are recommended for look-alike/sound-alike medications (LASA)?

Which safety measures are recommended for look-alike/sound-alike medications (LASA)?

• A. Ignore look-alike names and use only color-coded labels.
• B. Use only unit-dose packaging.
• C. Rely on memory to distinguish similar names.
• D. Implement double-checks and use tall man lettering when appropriate.

Answer: (D)

Safety around look-alike/sound-alike medications hinges on using proactive verification and clear name differentiation to prevent misidentification. Implementing double-checks means having two qualified professionals independently verify critical steps—such as prescribing, dispensing, and administering high-risk drugs—to confirm the correct drug, dose, route, and patient. This layered check adds a safety net where simple memory or quick visual checks can fail. Tall man lettering is another practical tool. By highlighting the distinguishing portions of similar drug names in uppercase letters (for example, combinations like predniSONE vs prednisoLONE), the eye catches the differences at a glance. It’s used when name similarity or packaging could lead to confusion and is most effective when applied as part of a broader safety program, including clinician education and system prompts. Color-coded labels or color schemes alone don’t resolve confusion about look- or sound-alike names, and relying on memory is risky because errors can occur under stress or fatigue. Unit-dose packaging helps with standardization and reduces some errors, but it doesn’t address the fundamental risk of similar-sounding or similar-looking names. The best approach combines independent verification with strategies like tall man lettering to create multiple layers of protection against LASA errors.

Safety around look-alike/sound-alike medications hinges on using proactive verification and clear name differentiation to prevent misidentification. Implementing double-checks means having two qualified professionals independently verify critical steps—such as prescribing, dispensing, and administering high-risk drugs—to confirm the correct drug, dose, route, and patient. This layered check adds a safety net where simple memory or quick visual checks can fail.

Tall man lettering is another practical tool. By highlighting the distinguishing portions of similar drug names in uppercase letters (for example, combinations like predniSONE vs prednisoLONE), the eye catches the differences at a glance. It’s used when name similarity or packaging could lead to confusion and is most effective when applied as part of a broader safety program, including clinician education and system prompts.

Color-coded labels or color schemes alone don’t resolve confusion about look- or sound-alike names, and relying on memory is risky because errors can occur under stress or fatigue. Unit-dose packaging helps with standardization and reduces some errors, but it doesn’t address the fundamental risk of similar-sounding or similar-looking names. The best approach combines independent verification with strategies like tall man lettering to create multiple layers of protection against LASA errors.